196 related articles for article (PubMed ID: 23315164)
1. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA
Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164
[TBL] [Abstract][Full Text] [Related]
2. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.
Shah MY; Vasanthakumar A; Barnes NY; Figueroa ME; Kamp A; Hendrick C; Ostler KR; Davis EM; Lin S; Anastasi J; Le Beau MM; Moskowitz IP; Melnick A; Pytel P; Godley LA
Cancer Res; 2010 Jul; 70(14):5840-50. PubMed ID: 20587527
[TBL] [Abstract][Full Text] [Related]
3. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract][Full Text] [Related]
4. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.
Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R
Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876
[TBL] [Abstract][Full Text] [Related]
5. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.
Peters SL; Hlady RA; Opavska J; Klinkebiel D; Novakova S; Smith LM; Lewis RE; Karpf AR; Simpson MA; Wu L; Opavsky R
Mol Cell Biol; 2013 Nov; 33(21):4321-33. PubMed ID: 24001767
[TBL] [Abstract][Full Text] [Related]
6. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis.
Hlady RA; Novakova S; Opavska J; Klinkebiel D; Peters SL; Bies J; Hannah J; Iqbal J; Anderson KM; Siebler HM; Smith LM; Greiner TC; Bastola D; Joshi S; Lockridge O; Simpson MA; Felsher DW; Wagner KU; Chan WC; Christman JK; Opavsky R
J Clin Invest; 2012 Jan; 122(1):163-77. PubMed ID: 22133874
[TBL] [Abstract][Full Text] [Related]
7. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
[TBL] [Abstract][Full Text] [Related]
8. Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.
Ostler KR; Yang Q; Looney TJ; Zhang L; Vasanthakumar A; Tian Y; Kocherginsky M; Raimondi SL; DeMaio JG; Salwen HR; Gu S; Chlenski A; Naranjo A; Gill A; Peddinti R; Lahn BT; Cohn SL; Godley LA
Cancer Res; 2012 Sep; 72(18):4714-23. PubMed ID: 22815530
[TBL] [Abstract][Full Text] [Related]
9. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
[TBL] [Abstract][Full Text] [Related]
10. DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas.
Alkebsi L; Handa H; Sasaki Y; Osaki Y; Yanagisawa K; Ogawa Y; Yokohama A; Hattori H; Koiso H; Saitoh T; Mitsui T; Tsukamoto N; Nojima Y; Murakami H
Leuk Res; 2013 Dec; 37(12):1662-7. PubMed ID: 24094886
[TBL] [Abstract][Full Text] [Related]
11. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation.
Hervouet E; Vallette FM; Cartron PF
Epigenetics; 2009 Oct; 4(7):487-99. PubMed ID: 19786833
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
[TBL] [Abstract][Full Text] [Related]
13. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.
Arrate MP; Vincent T; Odvody J; Kar R; Jones SN; Eischen CM
Cancer Res; 2010 Jul; 70(14):6083-92. PubMed ID: 20587524
[TBL] [Abstract][Full Text] [Related]
15. Bim is a suppressor of Myc-induced mouse B cell leukemia.
Egle A; Harris AW; Bouillet P; Cory S
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6164-9. PubMed ID: 15079075
[TBL] [Abstract][Full Text] [Related]
16. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
17. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.
Heideman MR; Wilting RH; Yanover E; Velds A; de Jong J; Kerkhoven RM; Jacobs H; Wessels LF; Dannenberg JH
Blood; 2013 Mar; 121(11):2038-50. PubMed ID: 23327920
[TBL] [Abstract][Full Text] [Related]
18. Splice variants DNMT3B4 and DNMT3B7 overexpression inhibit cell proliferation in 293A cell line.
Shao G; Zhang R; Zhang S; Jiang S; Liu Y; Zhang W; Zhang Y; Li J; Gong K; Hu XR; Jiang SW
In Vitro Cell Dev Biol Anim; 2013 May; 49(5):386-94. PubMed ID: 23636939
[TBL] [Abstract][Full Text] [Related]
19. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
[TBL] [Abstract][Full Text] [Related]
20. The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.
Forshell LP; Li Y; Forshell TZ; Rudelius M; Nilsson L; Keller U; Nilsson J
Oncotarget; 2011 Jun; 2(6):448-60. PubMed ID: 21646687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
